ACR Convergence 2021

November 5-9, 2021. All Virtual.

View by Number View by Title View Sessions

View by Date

Saturday, November 6, 2021

8:30AM-10:30AM: Antiphospholipid Syndrome Poster (0069–0083)

8:30AM-10:30AM: B Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster (0001–0010)

8:30AM-10:30AM: Epidemiology & Public Health Poster I: COVID-19 & Vaccination (0084–0117)

8:30AM-10:30AM: Fibromyalgia & Other Clinical Pain Syndromes Poster (0118–0127)

8:30AM-10:30AM: Health Services Research Poster I: Lupus, Inflammatory Arthritis, & More (0128–0148)

8:30AM-10:30AM: Imaging of Rheumatic Diseases Poster (0149–0182)

8:30AM-10:30AM: Miscellaneous Rheumatic & Inflammatory Diseases Poster I (0183–0209)

8:30AM-10:30AM: Osteoarthritis – Clinical Poster I (0210–0224)

8:30AM-10:30AM: Patient Outcomes, Preferences, & Attitudes Poster I: Impact (0225–0240)

8:30AM-10:30AM: Pediatric Rheumatology – Clinical Poster I: JIA (0241–0265)

8:30AM-10:30AM: Psychology/Social Sciences Poster (0266–0267)

8:30AM-10:30AM: RA – Diagnosis, Manifestations, & Outcomes Poster I: Cardiovascular Pulmonary Disease (0268–0295)

8:30AM-10:30AM: RA – Etiology & Pathogenesis Poster (0011–0045)

8:30AM-10:30AM: Sjögren's Syndrome – Basic & Clinical Science Poster (0296–0322)

8:30AM-10:30AM: SLE – Diagnosis, Manifestations, & Outcomes Poster I: Diagnosis (0323–0356)

8:30AM-10:30AM: Spondyloarthritis Including PsA – Basic Science Poster (0046–0068)

8:30AM-10:30AM: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes Poster I: Clinical Aspects of Axial Spondyloarthritis (0357–0386)

8:30AM-10:30AM: Systemic Sclerosis & Related Disorders – Clinical Poster I (0387–0413)

8:30AM-10:30AM: Vasculitis – ANCA-Associated Poster (0414–0436)

9:00AM-10:00AM: Abstracts: Immunological Complications of Therapy (0437–0440)

9:00AM-10:00AM: Abstracts: Muscle Biology, Myositis & Myopathies (0441–0444)

9:30AM-10:30AM: Abstracts: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science (0445–0448)

9:30AM-10:30AM: Abstracts: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes I (0449–0452)

10:30AM-11:30AM: Abstracts: Health Services Research (0462–0465)

10:30AM-11:30AM: Abstracts: Imaging of Rheumatic Diseases (0466–0469)

10:30AM-11:30AM: Abstracts: RA – Etiology & Pathogenesis (0458–0461)

10:30AM-12:00PM: Plenary I (0453–0457)

11:00AM-12:00PM: Abstracts: Fibromyalgia & Other Clinical Pain Syndromes (0474–0477)

11:00AM-12:00PM: Abstracts: SLE – Animal Models (0470–0473)

2:00PM-3:30PM: Abstracts: Osteoarthritis – Clinical (0478–0483)

2:00PM-3:00PM: Abstracts: Professional Education (0484–0487)

2:00PM-3:00PM: Abstracts: Spondyloarthritis Including PsA – Treatment I: Emerging Therapies (0488–0491)

3:30PM-4:30PM: Abstracts: Healthcare Disparities in Rheumatology (0492–0495)

3:30PM-5:00PM: Abstracts: Systemic Sclerosis & Related Disorders – Clinical (0496–0501)

3:30PM-5:00PM: Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders (0502–0507)

Sunday, November 7, 2021

8:30AM-10:30AM: Cytokines & Cell Trafficking Poster (0508–0516)

8:30AM-10:30AM: Epidemiology & Public Health Poster II: Inflammatory Arthritis – RA, SpA, & Gout (0560–0593)

8:30AM-10:30AM: Genetics, Genomics & Proteomics Poster (0517–0533)

8:30AM-10:30AM: Healthcare Disparities in Rheumatology Poster (0594–0622)

8:30AM-10:30AM: Measures & Measurement of Healthcare Quality Poster (0623–0659)

8:30AM-10:30AM: Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster I (0660–0682)

8:30AM-10:30AM: Muscle Biology, Myositis & Myopathies Poster (0683–0722)

8:30AM-10:30AM: Osteoarthritis – Clinical Poster II (0723–0738)

8:30AM-10:30AM: Patient Outcomes, Preferences, & Attitudes Poster II: Measurements (0739–0763)

8:30AM-10:30AM: Patient Perspectives Poster (PP01–PP09)

8:30AM-10:30AM: Pediatric Rheumatology – Clinical Poster II: SLE, JDM, & Juvenile Scleroderma (0764–0785)

8:30AM-10:30AM: RA – Diagnosis, Manifestations, & Outcomes Poster II: Miscellaneous Aspects of RA (0786–0812)

8:30AM-10:30AM: RA – Treatments Poster I: Comparative Effectiveness, Biosimilars, Withdrawal, & the Real World (0813–0845)

8:30AM-10:30AM: Research Methodology Poster (0846–0854)

8:30AM-10:30AM: SLE – Animal Models Poster (0534–0540)

8:30AM-10:30AM: SLE – Diagnosis, Manifestations, & Outcomes Poster II: Manifestations (0855–0896)

8:30AM-10:30AM: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes Poster II: Imaging in Spondyloarthritis (0897–0907)

8:30AM-10:30AM: Spondyloarthritis Including PsA – Treatment Poster I: Axial Spondyloarthritis (0908–0939)

8:30AM-10:30AM: Systemic Sclerosis & Related Disorders – Basic Science Poster (0541–0559)

9:00AM-10:00AM: Abstracts: Antiphospholipid Syndrome (0948–0951)

9:00AM-10:00AM: Abstracts: Osteoarthritis & Joint Biology – Basic Science (0940–0943)

9:00AM-10:00AM: Abstracts: Spondyloarthritis Including PsA – Basic Science (0944–0947)

9:00AM-10:00AM: Abstracts: Vasculitis – ANCA-Associated (0952–0955)

10:30AM-11:30AM: Abstracts: Infection-related Rheumatic Disease (0962–0965)

10:30AM-11:30AM: Abstracts: T Cell Biology & Targets in Autoimmune & Inflammatory Disease (0966–0969)

10:30AM-12:00PM: Plenary II (0956–0961)

2:00PM-3:30PM: Abstracts: Pediatric Rheumatology – Clinical (0974–0979)

2:00PM-3:00PM: Abstracts: RA – Diagnosis, Manifestations, & Outcomes I: Bugs & Drugs (0980–0983)

2:00PM-3:00PM: Abstracts: SLE – Etiology & Pathogenesis (0970–0973)

3:30PM-4:30PM: Abstracts: Sjögren's Syndrome – Basic & Clinical Science (0984–0987)

3:30PM-4:30PM: Patient Perspectives (PP10–PP13)

4:00PM-5:00PM: Abstracts: Epidemiology & Public Health I: Risk in Rheumatic Diseases (0988–0991)

Monday, November 8, 2021

8:30AM-10:30AM: Epidemiology & Public Health Poster III: Other Rheumatic & Musculoskeletal Diseases (1022–1060)

8:30AM-10:30AM: Health Services Research Poster II: Care Models and Innovation (1061–1082)

8:30AM-10:30AM: Innate Immunity Poster (0992–1006)

8:30AM-10:30AM: Miscellaneous Rheumatic & Inflammatory Diseases Poster II: Clinical Features & Diagnostics (1083–1117)

8:30AM-10:30AM: Osteoarthritis – Clinical Poster III (1118–1134)

8:30AM-10:30AM: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster (1135–1149)

8:30AM-10:30AM: Patient Education/Community Programs Poster (1150–1152)

8:30AM-10:30AM: Patient Outcomes, Preferences, & Attitudes Poster III: Patient Preferences (1153–1169)

8:30AM-10:30AM: Pediatric Rheumatology – Basic Science Poster (1007–1013)

8:30AM-10:30AM: Professional Education Poster (1170–1195)

8:30AM-10:30AM: RA – Animal Models Poster (1014–1021)

8:30AM-10:30AM: RA – Diagnosis, Manifestations, & Outcomes Poster III: Prediction, Biomarkers, & Treatment Response (1196–1222)

8:30AM-10:30AM: RA – Treatments Poster II: PROs, Biomarkers, & Systemic Inflammation (1223–1256)

8:30AM-10:30AM: SLE – Diagnosis, Manifestations, & Outcomes Poster III: Outcomes (1257–1303)

8:30AM-10:30AM: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes III: Comorbidities, Extra-muskuloskeletal Manifestations, & Related Conditions (1304–1328)

8:30AM-10:30AM: Spondyloarthritis Including PsA – Treatment Poster II: Psoriatic Arthritis I (1329–1363)

8:30AM-10:30AM: Systemic Sclerosis & Related Disorders – Clinical Poster II (1364–1390)

8:30AM-10:30AM: Vasculitis – Non-ANCA-Associated & Related Disorders Poster I: Giant Cell Arteritis & Polymyalgia Rheumatica (1391–1419)

9:00AM-10:00AM: Abstracts: SLE – Diagnosis, Manifestations, & Outcomes I: COVID-19 Vaccine Experience & Translational Science (1420–1423)

10:30AM-11:30AM: Abstracts: Innate Immunity (1430–1433)

10:30AM-11:30AM: Abstracts: Systemic Sclerosis & Related Disorders – Basic Science (1434–1437)

10:30AM-12:00PM: Plenary III (1424–1429)

2:00PM-3:30PM: Abstracts: Clinical Epidemiology (1446–1451)

2:00PM-3:00PM: Abstracts: Cytokines & Cell Trafficking (1438–1441)

2:00PM-3:00PM: Abstracts: RA – Treatments II: New Findings in Established Therapies (1442–1445)

3:30PM-5:00PM: Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases: New Insights into Therapies & Mechanisms of Disease (1452–1457)

3:30PM-5:00PM: Abstracts: SLE – Treatment: New Agents, Old Agents (1458–1463)

4:00PM-5:00PM: Abstracts: Reproductive Issues in Rheumatic Disorders (1464–1467)

Tuesday, November 9, 2021

8:30AM-10:30AM: Immunological Complications of Therapy Poster (1516–1529)

8:30AM-10:30AM: Infection-related Rheumatic Disease Poster (1530–1564)

8:30AM-10:30AM: Late-Breaking Posters (L01 - L15)

8:30AM-10:30AM: Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster II (1565–1583)

8:30AM-10:30AM: Orthopedics, Low Back Pain, & Rehabilitation Poster (1584–1588)

8:30AM-10:30AM: Osteoarthritis & Joint Biology – Basic Science Poster (1468–1479)

8:30AM-10:30AM: Patient Outcomes, Preferences, & Attitudes Poster IV: COVID-19 (1589–1613)

8:30AM-10:30AM: Pediatric Rheumatology – Clinical Poster III: Miscellaneous Rheumatic Disease (1614–1644)

8:30AM-10:30AM: RA – Diagnosis, Manifestations, & Outcomes Poster IV: Outcomes, Trajectory of Disease, & Epidemiology (1645–1673)

8:30AM-10:30AM: RA – Treatments Poster III: RA Treatments & Their Safety (1674–1710)

8:30AM-10:30AM: Reproductive Issues in Rheumatic Disorders Poster (1711–1731)

8:30AM-10:30AM: SLE – Etiology & Pathogenesis Poster (1480–1506)

8:30AM-10:30AM: SLE – Treatment Poster (1732–1772)

8:30AM-10:30AM: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes Poster IV: Clinical Aspects of PsA & Peripheral SpA (1773–1800)

8:30AM-10:30AM: Spondyloarthritis Including PsA – Treatment Poster III: Psoriatic Arthritis II (1801–1835)

8:30AM-10:30AM: Systemic Sclerosis & Related Disorders – Clinical Poster III (1836–1861)

8:30AM-10:30AM: T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster (1507–1515)

8:30AM-10:30AM: Vasculitis – Non-ANCA-Associated & Related Disorders Poster II (1862–1888)

9:00AM-10:00AM: Abstracts: RA – Animal Models (1889–1892)

10:30AM-11:30AM: Abstracts: Measures & Measurement of Healthcare Quality (1893–1896)

10:30AM-11:30AM: Abstracts: Metabolic & Crystal Arthropathies – Basic & Clinical Science (1897–1900)

10:30AM-11:30AM: Abstracts: Orthopedics, Low Back Pain, & Rehabilitation (1901–1904)

10:30AM-12:00PM: Late-Breaking Abstracts (L16 - L21)

2:00PM-3:00PM: Abstracts: B Cell Biology & Targets in Autoimmune & Inflammatory Disease (1905–1908)

2:00PM-3:30PM: Abstracts: Patient Outcomes, Preferences, & Attitudes (1909–1914)

2:00PM-3:30PM: Abstracts: RA – Diagnosis, Manifestations, & Outcomes II: Heart & Lung (1915–1918)

2:00PM-3:30PM: Abstracts: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes II (1919–1922)

3:30PM-4:30PM: Abstracts: Epidemiology & Public Health II: Inflammatory Arthritis (1923–1926)

3:30PM-4:30PM: Abstracts: Pediatric Rheumatology – Basic Science (1927–1930)

3:30PM-4:30PM: Abstracts: SLE – Diagnosis, Manifestations, & Outcomes II: Predictors & Longitudinal Outcomes (1931–1934)

4:00PM-5:00PM: Abstracts: Genetics, Genomics & Proteomics (1935–1938)

4:00PM-5:00PM: Abstracts: RA – Treatments I: Safety & Harms (1939–1942)

4:00PM-5:00PM: Abstracts: Spondyloarthritis Including PsA – Treatment II: Biologic Therapies (1943–1946)